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When lymphocytes obtained from persons or animals exhibiting delayed hyper- 
sensitivity are stimulated in vitro by specific antigen, they produce a number of 
soluble substances with various biologic activities including migration inhibitory 
factor  (MIF) 1 and  lymphocyte mitogenic factor  (LMF)  (1-4).  Since  delayed 
hypersensitivity reactions  have  been  generally  assumed  to  be  mediated  by 
thymus-dependent (T) lymphocytes, it has been further assumed that antigen- 
induced production of MIF  was  by  T  lymphocytes and  thus  its  presence or 
absence  reflected T-cell  function.  The  correlation  of macrophage  migration 
inhibition with delayed hypersensitivity and not with antibody production (2, 5, 
6),  the  production  of  MIF  by  lymphocytes from  patients  with  sex-linked 
agammaglobulinemia but not thymic aplasia (7), and the lack of MIF production 
in numerous immunodeficiency diseases linked with depressed delayed hyper- 
sensitivity and normal antibody production (8, 9) are part of the foundation for 
this conclusion. 
The availability of a new method of cell separation utilizing affinity column 
chromatography  which  allows  the  quantitative  recovery  of  virtually  pure 
populations of human T and B lymphocytes has permitted a re-evaluation of the 
functional properties of T and B cells (10, 11). Using this technique, Chess et al. 
have recently shown that both T  and B human blood  lymphocytes respond to 
mitogens such as phytohemagglutinin (PHA), concanavalin A, and pokeweed, 
but  only T-cell  populations  proliferate in  response to  specific soluble  or cell 
surface antigens (10, 11). 
In the present study, we have used this affinity column separation technique to 
critically evaluate the hypothesis that antigen-induced mediator production is 
the exclusive property of T lymphocytes. Highly purified T- and B-lymphocyte 
populations were stimulated by specific antigen and their ability to produce two 
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lymphocyte mediators, MIF and LMF, was assessed. Whereas  only T cells made 
LMF, both T and B cells produced MIF (12). Thus, the production of MIF, while 
correlating with cutaneous delayed hypersensitivity, does not solely reflect T-cell 
function but B-cell function as well. Under these circumstances, the explanation 
for the production or lack of production of MIF by lymphocytes obtained from 
patients with immunodeficiency disorders  requires  reinterpretation. 
Materials  and  Methods 
Cell Separation  Technique.  The method of Chess et al. was used (10, 11). Purified rabbit anti- 
human Fab  immunoglobulin was coupled to Sephadex G-200  using cyanogen bromide (10).  Hepa- 
rinized blood was  drawn by  venipuneture from  donors exhibiting cutaneous  delayed hypersensi- 
tivity to purified protein derivative of tuberculin {PPD), Candida,  or streptokinase-streptodornase 
(SK-SD) as well from donors lacking these sensitivities (13).  Mononuclear cells were separated by 
centrifugation in a Ficoll-Hypaque gradient (14). 98% of the mononuclear phagocytes were removed 
by incubation with carbonyl iron and subsequent exposure to a magnetic field. The lymphocyte-rich 
population, in medium TC-199 containing 5% fetal calf serum and 10  4 M sodium EDTA, was passed 
over a Sephadex anti-Fab column. The effluent cell population (nonretained) contained less than 2% 
cells bearing surface immunoglobulin when evaluated  by immunofluorescent-staining techniques 
{10). These cell populations will be referred to as T cells. The cells retained in the column were then 
eluted with medium TC-199  containing 1% normal human immunoglobulin (10).  These Ig-eluted 
cells were 95-98%  surface immunoglobulin positive as  assessed by  immunofiuorescence and  are 
referred to  as  B  cells.  There  was  a  95-100%  recovery of the  starting cell  population using  this 
immunoadsorbent technique. Cell viability as determined by trypan blue exclusion was greater than 
95%. 
Production  of  Lymphocyte  Mediators.  The  unseparated  and  column  purified  lymphocyte 
populations were washed twice in serum-free medium. They were adjusted to 5 ×  l0 s lymphocytes/ml 
in medium TC-199 containing 10% gamma globulin-free horse serum in the absence or presence of 10 
ttg/ml PPD, 50 U/ml SK-SD, or 0.01 ml/ml stock solution of Candida albicans, and incubated for 48 h 
at  37°C  in  a  5%  CO2-95% air  atmosphere. The  cultures  were  centrifuged to  remove  the  cells; 
supernates obtained from the control culture were reconstituted with antigen in the original amount. 
In  most experiments, these supernates were  assayed directly for MIF  or LMF  activity. In some 
experiments, the supernates were dialyzed, lyophilized, and applied to Sephadex G-100 columns, and 
the fractions were concentrated and assayed. 
Column Chromatography.  Lyophilized control and active supernates from T- or B-cell cultures 
were reconstituted to  2  ml with phosphate-buffered saline (pH 7.4) and applied to 2.5  ×  100-em 
columns containing Sephadex G-100 as previously described (15). The columns were calibrated with 
[I~SI]RSA and  [125I]chymotrypsinogen  as  markers  having  mol  wt  of 68,000  and  23,000  daltons, 
respectively. The eluate was pooled into four fractions: fractions I and II contained material eluting 
from the void volume of the column to the beginning of the elution of albumin; fraction III  (Kd 
0.08-0.19) contained material eluting with albumin; fraction IVb (Kd 0.33-0.45)  contained material 
eluting with molecules having the size of chymotrypsinogen  and is the region where peak MIF activity 
from unseparated lymphocyte populations is found (15); and fraction IVa contained material between 
the albumin and chymotrypsinogen markers. Each fraction was dialyzed against distilled water and 
lyophilized. Before assay the fractions were made up to ¼0 the original volume in medium TC-199 
containing 10% horse serum; these were sterilized by passage through a Millipore filter. The paired 
control and active fractions were assayed for MIF and LMF activity as described below. 
Assay for MIF Activity.  Unconcentrated supernates or  10-fold  concentrated Sephadex G-100 
fractions from control or antigen-stimulated T- or B-cell cultures were assayed for MIF activity on 
guinea pig macrophages in capillary tubes (16). The area of migration was drawn at 24 h, measured by 
planimetry, and the percent migration inhibition calculated by the following formula: % migration 
inhibition =  1.0 -  {area of migration in "active" supernate)/(area of migration in control supernate) 
×  100. 
Assay for LMF Activity.  Active (preincubated [P])  and control (reconstituted [R])  supernates ROCKLIN, MACDERMOTT, CHESS,  SCHLOSSMAN, AND DAVID  1305 
were assayed for mitogenic activity using lymphocytes from normal donors who lacked sensitivity to 
the  antigen used to  produce the  mediator (4).  Supernates were  tested at one-third or one-sixth 
dilutions in medium TC-199 containing 10% horse serum. The indicator lymphocytes were cultured 
for 6 days at 37°C at 2 x  l0 b cells/0.2 ml/well in quadruplicate in microtiter plates (Cooke Laboratory 
Products,  Cooke  Engineering Co.,  Alexandria, Va.).  18 h  before harvesting the cultures,  1 #Ci of 
[3H]thymidine (New England Nuclear, Boston, Mass.) with asp act of 6.7 mCi/mmol was added to 
each well and the acid precipitable material collected in a  MASH II apparatus (Microbiological 
Associates, Inc., Bethesda, Md.). The radioactivity was measured in a Tri-Carb liquid scintillation 
counter (Packard Instrument Co., Downers  Grove,  Ill.) and the mitogenic activity was  calculated 
as a stimulation index (SI = P/R) and a net increase in counts per minute (P -  R). 
Cell Treatment with 5-Bromo-2-Deoxyuridine (  BUdR  ) and Light.  In previous experiments it was 
shown that unseparated populations of antigen-stimulated lymphocytes treated with BUdR and light 
were capable of producing MIF despite the finding that over 95% of the proliferative response in the 
cultures  was  suppressed  (17).  Dividing lymphocytes treated  in  this  manner  are  thought  to  be 
destroyed after several cycles of division but  direct evidence of this  premise is lacking. These 
experiments were  interpreted to mean that nondividing lymphocytes were  producing MIF. Since 
unseparated populations were used previously, it was of interest in the present study to repeat these 
experiments using purified populations of T and B cells. Unseparated and T- or B-cell populations 
were  cultured  in  medium  TC-199  containing  15%  horse  serum  and  10 -~ M  BUdR.  Cells were 
incubated with or without antigen (PPD, Candida, or SK-SD) and received an exposure to visible 
light (1 h) on days 2, 3, and 4. After 6 days of culture the cells were washed and recultured for another 
48 h in the presence of the same antigen. The supernates were collected and assay for MIF activity. 
Results 
Production of MIF by T- and B-Cell Populations.  The data indicate that both 
T-  and  B-cell  populations  derived  from  the  blood  of  individuals  exhibiting 
cutaneous  delayed hypersensitivity to PPD,  Candida, or SK-SD  produced  MIF 
when  stimulated  in vitro by these  antigens  (Fig.  1). In three  experiments  using 
cells from PPD-positive donors, supernates from antigen-stimulated  T  or B  cells 
inhibited macrophage  migration by an average of 23% and 29%,  respectively. No 
MIF  was produced  in three experiments  using lymphocytes  from PPD-negative 
donors;  supernates  from  T-  and  B-cell  populations  inhibited  macrophage 
migration  by  -3%  and  5%,  respectively.  Similar  results  were  obtained  in 
experiments  where  Candida and SK-SD  were used  as antigens. 
It  was  then  of interest  to  quantitate  the  amount  of MIF  produced  by  each 
subpopulation.  Cultures were set up with 5  x  106 T  or B  cells, with and without 
antigen,  and  incubated  for  48  h.  The  supernates  obtained  from  these  cultures 
were serially diluted, and the highest dilution which still contained MIF activity 
was determined.  It can be seen in Fig. 2  that  MIF  produced by B  cells was still 
present  at  a  titer  of  1:4  whereas  T-cell  MIF  activity was  only detected  in  the 
undiluted  supernate. 
Chromatography  of Human  T- and B-CeU MIF.  Since it is well known that 
antigen-antibody  complexes  can  inhibit  macrophage  migration  (18),  it  was 
important  to further characterize the inhibitory activities obtained from each cell 
population.  In  three  experiments,  the  supernates  from  stimulated  and  control 
cell cultures were filtered over Sephadex  G-100 columns,  and the fractions were 
assayed for MIF  activity on guinea pig macrophages  (Fig. 3). It can be seen that 
peak  activity of both T-  and  B-cell MIF  were found  in  the same fraction  (IVb, 
23,000  daltons).  The  mean  T-cell MIF  inhibitory activity was 32%  and that  for 1306  MEDIATOR PRODUCTION BY  HUMAN T  AND B LYMPHOCYTES 
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Fro.  1.  MIF production by T  and B cells. Inhibition of migration of guinea pig macrophages 
by supernates obtained from different cell populations. Bars indicate mean MIF activity and 
symbols represent individual experiments. Note that MIF is produced by T  and B cells but 
only when sensitive donors were tested. 
the  B  cell  was  36%. Human  MIF  obtained  from  unseparated  lymphocyte 
populations has previously been shown to elute in the same fraction (15). In one 
out of three experiments, MIF activity was also found in fraction IVa but in none 
of the  other fractions. These  studies  indicate that  inhibition was  not  due  to 
antigen-antibody complexes which elute, because of their size, in fractions I and 
II. 
Effect of BUdR and Light on MIF Production by T and B  Cells.  It was shown 
in  previous  studies  that  antigen-induced  MIF  could  be  elaborated  by  a 
population  of nondividing lymphocytes (17).  Furthermore,  Chess  et  al.  have 
demonstrated that  T  cells  but  not  B  cells  proliferate  directly in  response  to 
antigen (11).  These findings taken together suggested that B lymphocytes could 
be the nondividing cells which were producing MIF. Experiments were carried 
out to examine this hypothesis and to determine whether or not the T cells which 
produce MIF are proliferating cells. 
Treatment of a population of antigen-stimulated lymphocytes with BUdR and 
light eliminates the dividing cells: cells undergoing antigen-induced proliferation 
incorporate BUdR into their DNA and are subsequently damaged and eliminated 
when  exposed  to  light.  As  is  shown  in  Fig.  4,  MIF  was  still  produced  by ROCKLIN,  MACDERMOTT,  CHESS, SCHLOSSMAN,  AND DAVID  1307 
unseparated lymphocyte populations pretreated with antigen, BUdR, and light 
in five of six experiments (mean 21% inhibition). In contrast, T-cell populations 
similarly  treated  did  not  produce  MIF  (mean  8%  inhibition).  The  control 
population  of T  cells  which  were  not  exposed  to  antigen  initially,  although 
pretreated with BUdR and light,  did produce MIF  (mean 21%  inhibition).  In 
contrast, in two experiments, B  cells pretreated with antigen, BUdR, and light 
behaved similarly to the unseparated population,  i.e.,  they were not inhibited 
from producing MIF. 
Production of LMF by T-CeU Populations.  Antigen-stimulated lymphocytes 
from sensitized donors elaborate a mitogenic factor which induced nonsensitized 
lymphocytes  to  incorporate  [3H]thymidine.  To  determine  which  cell  type 
produces LMF,  column-purified lymphocyte populations  were  obtained  from 
both  PPD  or  Candida-sensitive  and  -nonsensitive subjects.  In  each of these 
experiments,  the  unseparated  lymphocyte  population,  purified  T  cells  and 
purified B  cells were incubated in the presence or absence of the appropriate 
antigen. The supernates from these cultures were then assayed on indicator cells 
from individuals lacking sensitivity to the antigens being tested. In every case, 
there were three sets of indicator cells: unseparated lymphocytes, T  cells, and B 
cells. 
Tables I and II illustrate the results of experiments using PPD and Candida as 
antigens.  Unseparated  sensitive  lymphocytes stimulated  by  specific  antigen 
produced a mitogenic factor which induced unseparated cells, T cells, and B cells 
to proliferate. Sensitive T  cells from these individuals also produced mitogenic 
factor which caused a proliferative response in each group of the indicator cells. 
In contrast,  antigen-stimulated B  cells did not make LMF,  although they did 
respond  to  it.  The  production  of LMF,  like  MIF,  was  shown  to  be  antigen 
specific; lymphocytes from PPD or Candida-negative donors stimulated by these 
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FIG.  2.  Quantitation of MIF by T and B cells. Supernates from the lymphocyte cultures were 
serially diluted in culture medium. Note that B-cell MIF is still active at 1:4 whereas T-cell 
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antigens failed to elaborate a mitogenic factor for any of the indicator cells (Table 
III). 
Chromatography  of LMF from Human T Cells on Sephadex G-IO0.  Antigen- 
antibody  complexes can nonspecifically activate  lymphocytes to increase their 
DNA synthesis. Therefore, it was important to further characterize the mitogenic 
activity present in the T-cell supernates. 
In three experiments, supernates from PPD and Candida-sensitive donors were 
filtered on Sephadex G-100 and the fractions assayed for LMF using lymphocytes 
from negative donors (see Table IV). It can be seen that in each experiment the 
peak  mitogenic  activity  was detected  in  fraction  IVb  (mol wt 23,000  daltons) 
which  is the same region  where MIF activity is also detected.  Some mitogenic 
activity  was  also  found  in  fraction  IVa,  the  region  between the  albumin  and 
chymotrypsinogen markers. It is of note that no mitogenic activity was found in 
fractions I and II, the region where antigen-antibody complexes are eluted. 
Discussion 
The studies described here were undertaken to evaluate the capacity of purified 
T  and  B  lymphocytes to  produce  two  mediators,  MIF  and  LMF.  The  results 
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indicate that both T and B lymphocytes produce MIF; indeed, B cells made more 
than T  cells.  In contrast,  LMF was made by T  cells but not B  cells. These data 
necessitate  a  re-evaluation  of  the  working  hypothesis,  heretofore  held,  that 
antigen-induced mediator production is the exclusive property of T lymphocytes. 
Before discussing the implications of these findings, it is important to examine 
and evaluate the question: can the production of MIF by the B-cell population be 
due to a few contaminating T  cells? The results previously described by Chess et 
al. using this technique (10, 11) combined with the data presented here virtually 
exclude this possibility;  these are discussed below. 
As  described  by  Chess  et  al.,  the  cells  that  do  not  adhere  to  the  anti-Fab 
Sephadex  column,  the T-cell  population,  are 98% nonimmunoglobulin-bearing 
cells. These cells do not become immunoglobulin bearing when kept in culture for 
as long as 8 days, nor when incubated with human immunoglobulin or triggered 
by mitogens (10). Over 80% of these cells form E rosettes. On the other hand, the 
B-cell  population,  which is specifically  eluted from the column with human Ig, 
contains 98% immunoglobulin-bearing cells,  and less than 2% of this population 
form E rosettes. This population remains immunoglobulin bearing after culture. 
Both T- and B-cell populations contain approximately 2% monocytes as assessed 
by phagocytosis of latex particles. 
The  functional  studies  make  it  very  unlikely  that  the  cells  in  the  B-cell 
population without B-cell  characteristics  are T  cells responsible for the produc- 
tion of MIF in this population. First, the T-cell population responds to antigen by 
enhanced  [3H]thymidine  incorporation and contains the responsive  cells  in the 
mixed leukocyte culture reactions;  the B-cell population does not exhibit either 
of these functions (11).  Second,  the T-cell population contains the lymphocytes 1310  MEDIATOR  PRODUCTION  BY  HUMAN T  AND  B  LYMPHOCYTES 
TABLE I 
Mitogenic Factor 
Supernatant 
source (PPD 
positive) 
Indicator cells (PPD negative) 
T and B Cells  T Cells  B Cells 
P-R*  SI:~  P-R  SI  P-R  SI 
T and B cells 
1  1,155§  6.3  524  3.4  762  7.7 
2  1,008  6.3  738  5.4  1,497  10.7 
T cells 
1  1,437  8.5  499  4.1  1,373  11.5 
2  1,598  10.4  1,002  8.0  1,533  8.3 
B cells 
1  50  1.2  42  1.2  68  1.5 
2  55  1.2  11  1.1  120  1.6 
* cpm preincubated  cpm reconstituted (control). 
$ SI, P/R. 
§ cpm, mean of quadruplicate cultures. 
TABLE  II 
Mitogenic Factor 
Supernatant 
source ( Candida 
positive) 
Indicator cells (Candida negative) 
T and B cells  T cells  B cells 
P-R  SI  P-R  SI  P-R  SI 
T and B cells 
1  865  6.1  600  3.9  1,210  7.8 
2  1,056  6.5  366  2.8  468  4.9 
T cells 
1  1,345  9.5  674  5.2  1,440  5.1 
2  .742  4.7  387  2.9  762  5.6 
B cells 
1  16  0.9  38  1.2  102  1.4 
which are effectors  in cell-mediated cytotoxicity, whereas the B-cell population 
does not. 2 Third, the T  cells make LMF and the B  cells do not (Tables I and II). 
Fourth,  the MIF activity in the supernate from T  cells is lost when diluted 1:2 
while that from  B  cells is  still present at  1:4  (Fig.  2).  Fifth,  the T  cells do not 
produce MIF when pretreated with antigen, BUdR, and light, i.e. are proliferat- 
ing cells, but the B  cells still do, indicating that they are a  different population 
which need not proliferate (Fig. 4). Thus, any contaminating proliferating T  cells 
should have  been eliminated from  the  B-cell population in these  experiments. 
2  Sondel,  P.  M., L. Chess, R. P. MacDermott,  and S. F. Schlossman.  Immunologic functions of 
isolated human lymphocyte subpopulations. III. Specific allogeneic lymphoLysis  mediated by human 
T cells alone. Manuscript submitted for publication. ROCKLIN,  MACDERMOTT,  CHESS,  SCHLOSSMAN,  AND DAVID  1311 
Sixth,  in  previous  studies,  we  found  that  MIF  activity was  not  detected  in 
supernates obtained from antigen-stimulated lymphocyte cultures which were 
made  to  contain  as  many  as  10%  lymphocytes from  a  sensitive  donor,  the 
remaining 90% coming from a nonsensitive donor (unpublished observations). It 
thus seems impossible to attribute the production of MIF by B-cell populations 
to a few contaminating T  cells. The possibility that the B-cell MIF is dependent 
upon or  directed by a  few T  cells which themselves do not  make MIF would 
require the presence of a unique nonproliferating T cell exhibiting no other T-cell 
function; at present, this seems rather remote. 
Our finding that T  cells elaborate MIF when stimulated by specific antigen is 
in  agreement with studies by Yoshida et al.  who used guinea pig  lymphocyte 
populations  separated  by  rosetting  techniques  (19). On  the  other  hand,  our 
studies on B cells differ from these workers. They reported that B cells from spe- 
cifically sensitized guinea pigs did not produce MIF in response to protein anti- 
gens and hapten-protein conjugates with the exception of PPD, and that B cells 
produced MIF in response to this antigen whether they had been obtained from a 
PPD-sensitive  or  -nonsensitive guinea pig.  The  authors speculate that in this 
instance, PPD  was acting as  a  nonspecific B-cell  mitogen. In contrast,  in our 
studies, human B cells from nonsensitive donors did not produce MIF in response 
TABLE III 
Supernatant 
source (PPD 
negative, 
Candida 
negative) 
Indicator cells (PPD negative, Candida negative) 
T  and B cells  T  cells  B cells 
P-R  SI  P-R  SI  P-R  SI 
T and B cells 
PPD 
Candida 
T  cells 
PPD 
Candida 
B cells 
PPD 
Candida 
65  1.3  20  1.1  21  1.2 
2  1.0  7  1.1  28  1.2 
-3  1.0  50  1.3  31  1.2 
15  1.1  9  1.0  46  1.2 
31  1.1  -18  0.9  22  1.1 
42  1.2  -22  0.9  -13  0.9 
TABLE IV 
Mitogenic Factor 
Fraction (Sephadex G-100) 
I and II  III  IVA  IVB  V 
SI 
1 
2 
P-R (cpm) 
1 
2 
1.0  0.9  1.0  7.6  1.2 
0.9  1.5  9.7  29.0  -- 
1,075  -4,357  39  120,862  2,205 
-  5  27  558  2,045  -- 1312  MEDIATOR PRODUCTION  BY  HUMAN  T  AND  B LYMPHOCYTES 
to three antigens, PPD, SK-SD, and Candida. Thus, we found that both T and B 
cells made MIF in response to several antigens, but only if the lymphocytes were 
obtained from specifically sensitive donors. It will be of interest to determine the 
functional  properties  of  highly  purified  populations  of  guinea  pig  T  and  B 
lymphocytes obtained by affinity column techniques. 
Recently, it has been reported that  two other lymphocyte mediators,  chemo- 
tactic factor (20)  and  interferon (21),  are also produced by human  B  cells after 
being  stimulated  by PHA.  Further,  supernates  from  long-term  lymphoid  cell 
lines,  many  of them  bearing  surface  immunoglobulin,  have  been  reported  to 
contain mediator-like activity including MIF (22,  23). Most long-term lymphoid 
lines originate from B cells. 
Chromatographic  analysis of T- and B-cell MIF indicate that neither activity 
is  due to antigen-antibody  complexes as the MIF produced  by both cell types 
elutes from Sephadex G-100 in fraction IVb (23,000 daltons), the same location as 
MIF  from  unseparated  human  lymphocyte  populations.  Studies  in  which 
lymphocyte populations  were pretreated  with  antigen,  BUdR,  and  light  are of 
special interest as they further differentiate the lymphocyte populations making 
MIF  into  one  requiring  proliferating  cells  (T  lymphocytes)  and  one  of non- 
proliferating cells (B lymphocytes). Cells which are induced to proliferate in the 
presence of BUdR incorporate  the  nucleotide analogue of thymidine  into their 
DNA rendering  the  cell susceptible to damage  and  elimination  by exposure to 
light.  This  procedure effectively eliminated  the MIF-producing T  cells, but not 
the MIF-producing B cells. It is important  to recall that T  cells, but not B cells, 
exhibit antigen-induced  [3H]thymidine  incorporation  (11). Thus,  both antigen- 
sensitive and MIF-producing T lymphocytes are proliferating cells. The previous 
observation that some lymphocyte populations from patients with varying types 
of immunodeficiency  contain  cells that  undergo  antigen-induced  proliferation 
but do not make  MIF suggests the  existence of at  least two subpopulations of 
proliferating T  cells, one of which does not make MIF. 
It was of interest to determine which of the purified populations made more 
MIF.  Quantitative  determinations  of  the  MIF  activity  in  the  present  study 
indicate  that  B-cell populations  make  more  MIF  than  T  cells. This finding is 
consistent  with  the  results  of previous  experiments  in  which  pretreatment  of 
unseparated  lymphocytes (containing  approximately 20% B cells) with antigen, 
BUdR, and light did not significantly diminish detectable MIF production (17). 
Whereas MIF is produced by both T and B cells, LMF, is only made by T-cell 
populations. The production of LMF is antigen specific when PPD and Candida 
are used. Its effect, however, is nonspecific in that it increases the incorporation 
of  [SH]thymidine  into  lymphocytes  from  donors  who  lack  sensitivity  to  the 
antigen used to produce it. In addition,  LMF, when added to lymphocytes from 
specifically  sensitized  donors,  causes  more  [3H]thymidine  incorporation  than 
that caused by antigen  alone. 
LMF,  although  only produced  by T  cells,  induces  increased  [~H]thymidine 
incorporation  by  both  purified  T-  and  B-cell  populations.  Geha  et  al.  have 
previously  reported  that  enriched  human  T-cell  populations  isolated  from 
discontinuous  albumin  gradients  produce  LMF  which  caused  populations  of 
enriched T or B cells to take up  [3H]thymidine (24, 25). They further stated that ROCKLIN, MACDERMOTT, CHESS, SCHLOSSMAN, AND DAVID  1313 
their material induced antibody synthesis in B cells obtained from donors having 
sensitivity to specific antigen  (25). 
Chromatographic  analysis of LMF indicates that its mitogenic activity is not 
due to antigen-antibody complexes as it too elutes from Sephadex G-100 columns 
in fraction IVb (23,000 daltons), the same location where MIF is found. Two lines 
of evidence suggest that LMF is quite distinct from MIF. First, B-cell MIF has no 
LMF  activity.  Secondly,  some  patients  have  lymphocytes  which  respond  to 
antigen by producing LMF but not MIF (26). The existence of subpopulations of 
lymphocytes making separate and distinct mediators most easily explains these 
findings.  If one argues that they are the same molecule, it is then necessary to 
postulate the production of regulatory substances which can inhibit one activity 
but not the other. This hypothesis seems unlikely at this time, but it is subject to 
analysis. 
At this juncture,  it  is  necessary to  re-examine  the  interpretation  of certain 
studies  carried  out  with  peripheral  blood  lymphocytes  from  patients  with 
immunodeficiency  diseases  in  the  light  of the  present  findings.  The  lack  of 
antigen-induced  MIF  production  by  lymphocytes  from  patients  with  thymic 
aplasia using such common antigens as SK-SD and Candida (7) now implies both 
a T- and B-cell defect. The lack of a  proliferative lymphocyte response to PHA 
has similar implications. Such patients are capable of mounting certain antibody 
responses  and  thus  some  B-cell  function  is  intact.  Since  the  defect  in  these 
patients  is overcome by thymus grafting,  it would appear that the  ability of T 
and  B  cells  to  become  sensitized  to  antigen  or  to  develop  responsiveness  to 
mitogen is still a thymus-dependent  process. 
Results  from  patients  with  chronic  mucocutaneous  candidiasis  present  a 
greater paradox.  Many such patients exhibit normal T-cell function as assessed 
by  [3H]thymidine  incorporation  in  response  to  Candida  antigen,  and  normal 
B-cell function measured by high titer antibody to the same antigen  (27). Their 
cells also respond normally to PHA. However, in many cases, their lymphocytes 
do not make MIF in response to Candida antigen,  implying a  defect in both T 
and  B  cells,  and  further,  these  patients  do  not  exhibit  cutaneous  delayed 
hypersensitivity  to  this  antigen  (28).  Clearly,  there  exists  a  multiplicity  of 
subpopulations of Candida-sensitive T  and B cells; the possible requirement for 
both  in  the  manifestation  of cutaneous  delayed  hypersensitivity  needs  to  be 
further elucidated. 
How can the finding that B cells make antibody to certain antigens but do not 
produce MIF when stimulated by the same antigen be explained? Possibly, there 
are subpopulations of B  cells. Further,  a  continuous T-cell suppression of such 
B-cell responses might exist. It would be of interest to determine if B cells from 
such individuals could make MIF if the T  cells were removed. 
The observation that  B  cells make MIF but do not proliferate in response to 
antigen  may  explain  the  finding  that  lymphocytes  from  some  patients  with 
Wiskott-Aldrich syndrome who are treated with transfer factor produce MIF but 
do not proliferate in response to antigen (29).  In these cases, transfer factor may 
be turning  on the B  lymphocytes, but not the T  cells. On the other hand,  such 
patients,  after transfer factor, exhibit positive cutaneous delayed hypersensitiv- 
ity. Could this be a  B-cell manifestation  in this case? It would appear that the 1314  MEDIATOR  PRODUCTION  BY  HUMAN  T  AND  B  LYMPHOCYTES 
relationship  of T  and  B  lymphocytes to cutaneous delayed hypersensitivity in 
man requires re-exploration. 
At  present,  no  single  in  vitro  assay  of  lymphocyte  function  correlates 
completely with  in vivo cutaneous delayed hypersensitivity.  Antigen-mediated 
["H]thymidine  incorporation  (11)  and  LMF production  clearly  reflect in  vitro 
T-cell  function;  however,  in  some  diseases  such  as  in  sarcoidosis  or  ragweed 
allergy, these responses may be positive in the absence of cutaneous hypersensi- 
tivity or MIF production (8, 26). As both T and B cells produce MIF, it cannot be 
considered an assay of T-cell function in man. It should be emphasized, however, 
that  lymphocytes must be obtained from donors exhibiting delayed hypersensi- 
tivity to the antigen used to elicit MIF production. Thus, with some exceptions, 
MIF production is associated with the presence of delayed hypersensitivity, but 
not with a particular cell type. Clearly, the manifestations of delayed hypersensi- 
tivity in man cannot be explained completely by the present schemes and require 
further investigation. 
Summary 
Highly purified populations of T and B lymphocytes obtained by affinity column 
separation  were  stimulated  by  antigen  and  their  ability  to  produce  two 
mediators,  migration  inhibitory  factor (MIF)  and  lymphocyte mitogenic  factor 
(LMF) was assessed. Both T- and B-cell populations made MIF; the production 
of  MIF  was  antigen-specific  using  purified  protein  derivative  of  tuberculin, 
streptokinase-streptodornase,  and  Candida  antigens.  The  MIF  activity  from 
both populations  could not be attributed to antigen-antibody  complexes as the 
inhibitory  activity  eluted  from  Sephadex  G-100  columns  in  the  same  region 
corresponding to tool wt 23,000 daltons. Further studies indicate that the T  cells 
producing MIF are proliferating cells whereas the B cells producing this mediator 
are not. 
In  contrast,  LMF  was  made  only  by  T  cells  and  not  B  cells  when  these 
populations  were stimulated  by antigen.  The LMF induced the  [~H]thymidine 
incorporation into both T  and B cells obtained from donors lacking sensitivity to 
the  antigens  used  to  elicit  the  factor.  Chromatographic  studies  indicate  that 
LMF eluted from Sephadex G-100 in a  fraction of mol wt 23,000 daltons where 
MIF is also found; however, since B cells produce MIF but not LMF, these two 
factors appear to be distinct from one another. 
Some of the implications of these findings are discussed. The explanation for 
the  production  or  lack  of production  of MIF  by  lymphocytes  obtained  from 
patients with immunodeficiency disorders requires reinterpretation. 
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